Literature DB >> 17044841

Hormonal changes throughout life in women.

Howard A Zacur1.   

Abstract

The changes in hormonal milieu associated with menarche, pregnancy, lactation, and menopause are frequently accompanied by changes in the patterns and frequency of migraine. Migraine headache is more common in females and, for many women, the onset of this condition occurs at menarche. As many as 60% of women migraineurs report an association between migraine and menstruation, and evidence suggests that estrogen withdrawal may be a trigger for menstrual migraine in susceptible women. Moreover, in the majority of women, migraine frequency increases during the pill-free interval with oral contraceptive use and during the postpartum period, which are other times of decreasing estrogen levels. Migraine frequency tends to decrease during periods of increasing or stable estrogen levels. For these reasons, the numerous neuroendocrine effects elicited by estrogen have been evaluated to explain its role in migraine. Overall, estrogen appears to be a key factor in menstrual migraine, but it is likely to be only one of several factors that act in concert to trigger migraine in susceptible women. Understanding the relationship of the different hormonal milieus through the natural course of women's lives can guide diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044841     DOI: 10.1111/j.1526-4610.2006.00554.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  11 in total

1.  Acute headache diagnosis in pregnant women: a hospital-based study.

Authors:  Matthew S Robbins; Constantine Farmakidis; Ashlesha K Dayal; Richard B Lipton
Journal:  Neurology       Date:  2015-08-19       Impact factor: 9.910

2.  Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches.

Authors:  Lynne T Shuster; Stephanie S Faubion; Richa Sood; Petra M Casey
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

3.  Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer.

Authors:  Amanda I Phipps; Garnet L Anderson; Barbara B Cochrane; Christopher I Li; Jean Wactawski-Wende; Gloria Y F Ho; Mary Jo O'Sullivan; Polly A Newcomb
Journal:  Horm Cancer       Date:  2012-07-24       Impact factor: 3.869

4.  The impact of pregnancy on headache evaluation in the emergency department, a retrospective cohort study.

Authors:  Ian Waldman; Stephen Wagner; Kristine Posadas; Timothy A Deimling
Journal:  Emerg Radiol       Date:  2017-04-05

5.  Cortical subarachnoid hemorrhage associated with reversible cerebral vasoconstriction syndrome after elective triplet cesarean delivery.

Authors:  Beatrice Albano; Massimo Del Sette; Luca Roccatagliata; Carlo Gandolfo; Alberto Primavera
Journal:  Neurol Sci       Date:  2011-03-08       Impact factor: 3.307

6.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  Altered trigeminal system excitability in menstrual migraine patients.

Authors:  Ayhan Varlibas; A Kemal Erdemoglu
Journal:  J Headache Pain       Date:  2009-06-04       Impact factor: 7.277

8.  Migraine history and breast cancer risk among postmenopausal women.

Authors:  Christopher I Li; Robert W Mathes; Elizabeth C Bluhm; Bette Caan; Mary F Cavanagh; Rowan T Chlebowski; Yvonne Michael; Mary Jo O'Sullivan; Marcia L Stefanick; Ross Prentice
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

9.  Evaluation of relationship between breast cancer and migraine.

Authors:  Abbas Ghorbani; Azam Moradi; Abbas Gookizadeh; Saman Jokar; Seyed Ali Sonbolestan
Journal:  Adv Biomed Res       Date:  2015-01-06

10.  Influence of physiologic hormonal modification and of hormonal treatment in a patient with a history of migraine with aura.

Authors:  Ferdinando Maggioni; Antonio Palmieri; Michele Tropea; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2008-02-12       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.